BIG
ONC

Brooklyn Investment Group’s BeOne Medicines Ltd ONC Stock Holding History

Brooklyn Investment Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$744K Buy
2,505
+557
+29% +$180K 0.02% 730
2025
Q4 		$604K Buy
+1,948
New +$638K 0.03% 550
2025
Q3 		– Sell
-596
Closed -$144K – 2812
2025
Q2 		$144K Buy
596
+349
+141% +$85.6K 0.02% 756
2025
Q1 		$67.2K Buy
247
+209
+550% +$48.9K 0.01% 656
2024
Q4 		$7.02K Buy
+38
New +$7.76K ﹤0.01% 1103

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Brooklyn Investment Group's ONC Position: Q1 2026 in Review

Brooklyn Investment Group increased its BeOne Medicines Ltd (ONC) stake by 29% in Q1 2026, buying an estimated $180K and bringing the position to 2,505 shares worth $744K. The position accounts for 0.02% of the portfolio, ranked #730.

Brooklyn Investment Group first reported a position in ONC in Q4 2024 and has held it in 5 quarters since. 282 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Brooklyn Investment Group held 2,505 shares of BeOne Medicines Ltd worth $744K as of Q1 2026.
  • Brooklyn Investment Group bought 557 BeOne Medicines Ltd shares in Q1 2026, an estimated $180K.
  • BeOne Medicines Ltd made up 0.02% of Brooklyn Investment Group's portfolio in Q1 2026, its #730 holding.
  • Brooklyn Investment Group first reported a position in BeOne Medicines Ltd in Q4 2024 and has held it in 5 quarters since.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.